Article - FDA Clears Siemens' AI-Based MRI Interpretation Assistants

The Food and Drug Administration (FDA) has cleared two additional Siemens Healthineers artificial intelligence-based software assistants in the AI-Rad Companion family. The AI-Rad Companion Prostate MR for Biopsy Support automatically segments the prostate on MRI images and enables radiologists to mark lesions, facilitating targeted prostate biopsies. "These new AI-Rad Companion applications for MR exams in the brain and prostate regions will help physicians manage their workloads and achieve a patient-focused decision-making process to increase efficiency and improve the quality of care," said Peter Shen, Vice President of Innovation and Digital Business at Siemens Healthineers North America. The AI-Rad Companion Brain MR for Morphometry Analysis supports brain volumetry, which involves measuring the volume of gray matter (nerve cells), white matter (nerve cell connections), and cerebrospinal fluid in various segments of the brain and comparing the results to normal volumes. In typical clinical presentation and when combined with independent confirmation, reduced volume may indicate Parkinson's disease, Alzheimer's disease, or other forms of dementia.¹